Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
The molecule consists of a modified amino acid sequence based on the glucagon backbone and includes targeted substitutions that improve resistance to enzymatic degradation while maintaining receptor binding capability
Patients with FBS 126 mg/dL, HbA1c 6.5%, and/or currently using antidiabetic medication were defined as having diabetes according to the criteria of the Japan Diabetes Society [14]
and 2022YFC2703105 to H.E.X.)
More studies conducted with female rodent models and human subjects are needed to address these issues to ensure better maternal and fetal outcomes
doi: 10.1074/jbc.RA118.002486 192 DubotPBoisseauNCenedeseP
US$ 27.60
US$ 22.04
US$ 27.49
US$ 24.64
US$ 23.51
US$ 27.42
